PlexusDx's Precision Peptide Genetic Test analyzes variants in MC4R, and other peptide-pathway genes that influence appetite sensitivity, gut motility response, and overall GLP-1 tolerability
Early identification of serious complications improves outcomes and allows for appropriate treatment modifications
Understanding their mechanism of action provides a framework for optimizing efficacy, minimizing side effects, and expanding applications beyond diabetes to include other areas such as the treatment of obesity, cardiovascular diseases, non-alcoholic fatty liver disease (NAFLD), and even neurodegeneration
GLP-1 medications are not the destination
Excitonic connectivity between photosystem II units: what is it, and how to measure it
As a result, there are no clinical trials to suggest a potential dosing regime for CJC-1295/ipamorelin